Feng Li is the founder of Mabworks. Mabworks has raised $160M in total funding. Latest round: Series C. Based in Beijing, China.
Feng Li is the chairman of Mabworks, a China-based biopharmaceutical company. Mabworks is developing monoclonal antibody-based treatments for diseases including cancer, and has 15 assets in clinical trials in China and the US. The company recently completed a $160 million Series C funding round.
Full founder directory · Investor directory · Company funding database · Fundraising library